Search Results 501-510 of 13417 for BPC-157
About this study. The purpose of this study is to assess the safety, tolerability and pharmacokinetics (PK) of CYT-0851 in patients with relapsed/refractory ...
cell therapy. Displaying 157 studies. A Study of the Safety of Unlicensed, Investigational Cord Blood Units Manufactured by the National Cord Blood Program ...
This trial also studies the outcomes of patients with mixed phenotype acute leukemia (MPAL), and B-lymphoblastic lymphoma (B-LLy) when treated with ALL therapy ...
The purpose of the study is to learn more about inflammatory diseases of the central nervous system (CNS) by collecting patient information, blood sample (which ...
'Zombie' cells spark inflammation in severe fatty liver disease, Mayo Clinic researchers find. ROCHESTER, Minn. — Mayo Clinic researchers have uncovered how ...
Ixekizumab is a recombinant high-affinity fully human monoclonal antibody that targets IL-17A Immunoglobulin gamma-1 (IgG1)/kappa-class. The purpose of this ...
The drug, BT5528, is designed to find a specific protein called EphA2. The main aims of the study are to see how well the drug works against the tumor (efficacy) ...
Removing colorectal cancer (CRC) can be challenging due to tumor location, size and stage. However, Mayo Clinic Surgery finds that more than 50% of ...
The Gut Microbiome Lab at Mayo Clinic brings together gastroenterology experts to drive innovative research on how gut microbes influence health and disease.
The purpose of this study is to assess safety and efficacy of SER-109 in reducing recurrence of Clostridium difficile infection (CDI) in adults who had a CDI ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Mayo Clinic researchers drive discoveries that improve detection, diagnosis and treatment. Your quick message to them means so much.